UK markets open in 43 minutes

Traws Pharma, Inc. (TRAW)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.6397-0.0013 (-0.20%)
At close: 04:00PM EDT
0.6600 +0.02 (+3.17%)
After hours: 07:17PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
226
226
226
226
231
Operating expenses
Research development
9,378
11,430
11,406
7,297
16,898
Selling general and administrative
8,504
9,094
8,447
9,425
8,326
Total operating expenses
17,882
20,524
19,853
16,722
25,224
Operating income or loss
-17,656
-20,298
-19,627
-16,496
-24,993
Total other income/expenses net
348
1,350
663
333
-160
Income before tax
-17,308
-18,948
-18,964
-16,163
-25,153
Income tax expense
-
-
-
0
4
Income from continuing operations
-17,308
-18,948
-18,964
-16,163
-25,157
Net income
-17,308
-18,948
-18,964
-16,163
-25,157
Net income available to common shareholders
-17,308
-18,948
-18,964
-16,163
-25,157
Basic EPS
-0.96
-0.90
-0.91
-0.96
-2.17
Diluted EPS
-0.96
-0.90
-0.91
-0.96
-2.17
Basic average shares
20,967
20,989
20,908
16,832
11,602
Diluted average shares
20,967
20,989
20,908
16,832
11,602